StockIQ.techUnitedHealth Group Inc. (UNH) Stock Analysis
Free AI-powered analysis and research for UnitedHealth Group Inc. stock
Sector: Healthcare
UNH snapshot
Data as of 3 Nov 2026 close. Updated daily.
UnitedHealth Group Inc. scores 53/100 on StockIQ's model, which reads as mixed signals overall. The price is above its 200-day average and at 71% of its 52-week range, up 20.6% over the past year. Latest reported figures show a profit margin of 3.5%, return on equity of 15.8% and revenue growth of -0.4%.
What is driving the score
- RSI Neutral: +5
- Uptrend: +7
- MACD Bearish: -8
- Weak Profit Margin (3.5%): -8
- Low Liquidity (0.74 Current Ratio): -10
- Strong ROE (15.8%): +5
- Strong Long-term Uptrend: +8
- Healthy Momentum (+20.6% over 1 year): +7
- Low Volume (0.2x): -3
Automated, general information only – not financial advice. Scores can be wrong. How the score works
Full UNH report
UnitedHealth Group Inc. (UNH) is listed in the Healthcare sector. The snapshot on this page updates daily; run a full report for the complete breakdown.
Analyze UNH Now →📰 Latest Update
‘We Need to Break Up Big Medicine’: Elizabeth Warren Says Trump DOJ Gave UnitedHealth ‘More Power’ in $3.3 Billion Amedisys Deal
Tue, November 3, 2026 at 2:30 PM UTC 4 min read
Senator Elizabeth Warren criticized the Trump administration for allowing UnitedHealth Group Inc. to acquire Amedisys Inc. for $3.3 billion, claiming it increases the insurer's power to raise costs and deny care. She argues that the deal consolidates too much control over patient care, insurance, and prescriptions under one company, advocating for the breakup of vertically integrated healthcare firms to protect patients. Warren has co-sponsored the Patients Before Monopolies Act to address these concerns.